Xuyue Liu
Overview
Explore the profile of Xuyue Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li K, Wang J, Liu X, Dang Y, Wang K, Li M, et al.
Sci Rep
. 2025 Jan;
15(1):2802.
PMID: 39843899
Endometriosis (EM) is a chronic disease that can cause pain and infertility in patients. As is well known, immune cell infiltrations (ICIs) play important roles in the pathogenesis of EM....
2.
Liu X, Zhang R, Liu L, Zhi S, Feng X, Shen Y, et al.
Mol Carcinog
. 2024 Oct;
64(1):138-151.
PMID: 39436118
Liver cancer is the third leading cause of cancer-related deaths worldwide, with hepatocellular carcinoma (HCC) accounting for 85% of liver cancer-related deaths. Autophagy controls HCC cell growth, invasion, metastasis, drug...
3.
Zhang R, Shen Y, Zhang Q, Feng X, Liu X, Huo X, et al.
Cell Death Dis
. 2023 Dec;
14(12):850.
PMID: 38123542
Lung metastasis is the major cause of death in patients with triple-negative breast cancer (TNBC). Tumor-associated macrophages (TAMs) represent the M2-like phenotype with potent immunosuppressive activity, and play a pro-tumor...
4.
Liu L, Zhang X, Zhang R, Wang L, Zhi S, Feng X, et al.
Cell Death Dis
. 2023 Oct;
14(10):698.
PMID: 37875506
Disturbance in the redox balance of alveolar epithelial cells (AECs) was considered as a causal factor for pulmonary fibrosis. The regulatory mechanisms of redox hemostasis in the development of pulmonary...
5.
A Clinically Translatable Ternary Platinum(IV) Prodrug for Synergistically Reversing Drug Resistance
Liu Y, Wang D, Liu H, Liu L, Li S, Zhou Z, et al.
J Med Chem
. 2023 Mar;
66(6):4045-4058.
PMID: 36897884
Scalable production of a clinically translatable formulation with enhanced therapeutic efficacy against cisplatin-resistant tumors without the use of any clinically unapproved reagents and additional manipulation remains a challenge. For this...
6.
Zhang R, Zhang X, Zhang W, Cui W, Xiao Y, Liu L, et al.
Mol Cancer Res
. 2022 Oct;
21(2):115-126.
PMID: 36287177
Implications: This study identifies that Sohlh2 directly manipulates LncRNA-H19 transcription and suppresses the β-catenin signaling pathway and the Sohlh2/LncRNA-H19/miR-141/β-catenin signaling pathway plays an essential role in the stemness of colon...
7.
Liu X, Liang B, Hong X, Long J
Front Chem
. 2022 Apr;
10:870541.
PMID: 35464230
To enhance the electrochemical performance of MnO/graphene composite, herein, thermally-exfoliated graphite (TE-G) is adopted as a raw material, and a hydrothermal reaction is conducted to achieve the exfoliation of TE-G...
8.
Zhang G, Liu X, Jian A, Zheng K, Wang H, Hao J, et al.
PLoS One
. 2022 Mar;
17(3):e0265069.
PMID: 35294478
Background: Cholangiocarcinoma (CCA) is reported as an aggressive cancer which leads to high mortality and no effective therapeutic target has yet been discovered. Surgical resection is the main method to...
9.
Liu Y, Cui W, Zhang R, Zhi S, Liu L, Liu X, et al.
Front Oncol
. 2022 Feb;
11:769493.
PMID: 35127476
Background: Renal cell carcinoma is the most common malignant tumor of the kidney. The 5-year survival of renal cell carcinoma with distant metastasis is very low. Sohlh2 is a newly...
10.
Zhang G, Liu X, Sun Z, Feng X, Wang H, Hao J, et al.
BMC Cancer
. 2022 Jan;
22(1):5.
PMID: 34979994
Background: Intrahepatic cholangiocarcinoma (ICC) is a type of malignant tumor ranking the second in the incidence of primary liver cancer following hepatocellular carcinoma. Both the morbidity and mortality have been...